New Enterprise Associates 17, L.P. has filed 29 insider transactions across 4 companies since April 2024.
Most recent transaction: a purchase of 242945 shares of Korro Bio, Inc. ($KRRO) on March 10, 2026.
Activity breakdown: 7 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Korro Bio, Inc. | $KRRO | New Enterprise Associates 17, L.P. | Not found | P | Pre-Funded Warrants | 242945 | $11.11 | 242,945.0000 | 9,417,295 | 9999.99% | 2.58% |
| March 10, 2026 | Korro Bio, Inc. | $KRRO | New Enterprise Associates 17, L.P. | Not found | P | Common Stock | 207100 | $11.11 | 1,297,893.0000 | 9,417,295 | 18.99% | 2.20% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Series B Preferred Stock | 1619240 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Common Stock | 737962 | $0.00 | 5,097,538.0000 | 0 | 16.93% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | P | Common Stock | 937500 | $16.00 | 6,035,038.0000 | 0 | 18.39% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Common Stock | 1619240 | $0.00 | 1,619,240.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Common Stock | 1370168 | $0.00 | 2,989,408.0000 | 0 | 84.62% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Common Stock | 1370168 | $0.00 | 4,359,576.0000 | 0 | 45.83% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Series C-2 Preferred Stock | 1370168 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Series D Preferred Stock | 737962 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | New Enterprise Associates 17, L.P. | Not found | C | Series C-1 Preferred Stock | 1370168 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | A | Warrant (Right to Buy) | 186128 | $0.00 | 186,128.0000 | 9,024,240 | 9999.99% | 2.06% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | X | Common Stock | 189195 | $0.01 | 488,982.0000 | 9,024,240 | 63.11% | 2.10% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | S | Common Stock | 280 | $6.75 | 488,702.0000 | 9,024,240 | 0.06% | 0.00% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | M | Common Stock | 186128 | $0.01 | 674,830.0000 | 9,024,240 | 38.09% | 2.06% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | F | Common Stock | 276 | $6.75 | 674,554.0000 | 9,024,240 | 0.04% | 0.00% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | D | Common Stock | 674554 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 7.47% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | X | Warrant (Right to Buy) | 189195 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 2.10% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | M | Warrant (Right to Buy) | 186128 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 2.06% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | D | Series A Convertible Perpetual Preferred Stock | 75000 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 0.83% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | D | Series B Convertible Perpetual Preferred Stock | 37700 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 0.42% |
| Oct. 1, 2024 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | P | Warrant (Right to Buy) | 61865 | $0.00 | 185,594.0000 | 0 | 50.00% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | New Enterprise Associates 17, L.P. | Not found | C | Common Stock | 2091383 | $0.00 | 3,114,486.0000 | 0 | 204.42% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | New Enterprise Associates 17, L.P. | Not found | P | Common Stock | 500000 | $16.00 | 3,614,486.0000 | 0 | 16.05% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | New Enterprise Associates 17, L.P. | Not found | C | Common Stock | 1023103 | $0.00 | 1,023,103.0000 | 0 | 9999.99% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | New Enterprise Associates 17, L.P. | Not found | C | Series B Convertible Preferred Stock | 25142840 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | New Enterprise Associates 17, L.P. | Not found | C | Series A Convertible Preferred Stock | 12299854 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 22, 2024 | Korro Bio, Inc. | $KRRO | New Enterprise Associates 17, L.P. | Not found | P | Common Stock | 17857 | $56.00 | 1,090,793.0000 | 0 | 1.66% | 0.00% |
| April 8, 2024 | NeueHealth, Inc. | $NEUE | New Enterprise Associates 17, L.P. | Not found | P | Warrant (Right to Buy) | 123729 | $0.00 | 123,729.0000 | 0 | 9999.99% | 0.00% |